🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Terminated
Location
Rocky Mountain Cancer Centers
Start Date
2001-10
Trial ID
NCT00041288
RATIONALE: Bone marrow transplantation may be able to replace immune cells ...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2000-02
Trial ID
NCT00005988
This is a 5-year project, involving 185 partners from 46 countries ((110 in...
Status
Completed
Location
Istituto Giannina Gaslini
Start Date
2006-05-31
Trial ID
NCT00323960
Treatments Being Tested
RATIONALE: A peripheral stem cell, bone marrow, or umbilical cord blood tra...
Status
Completed
Location
Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
Start Date
2005-04
Trial ID
NCT00112645
The purpose of this study is to determine the response and toxicity rate of...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2022-01-01
Trial ID
NCT05166967
Treatments Being Tested
This retrospective study aims to assess the effectiveness of systemic treat...
Status
Completed
Location
Erasmus MC
Start Date
2022-09-23
Trial ID
NCT06512766
Treatments Being Tested
The objectives of this prospective non-interventional study are to characte...
Status
Recruiting
Location
Cahaba Dermatology & Skin Health Center- Site Number : 8400006
Start Date
2025-11-17
Trial ID
NCT07290803
This is a phase II multi-center, randomized, double blind, placebo-controll...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2013-02-01
Trial ID
NCT01743131
Background: The mainstay of therapy for newly diagnosed multiple myeloma p...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2001-02-08
Trial ID
NCT00006184
RATIONALE: Monoclonal antibodies such as gemtuzumab ozogamicin can locate c...
Status
Completed
Location
Fred Hutchinson Cancer Research Center
Start Date
2000-10
Trial ID
NCT00008151